PH Pharma Industry First to Adopt FDA Code of Ethics

Article excerpt

The Philippines has become the first country to formally adopt a regional voluntary code of business ethics for the biopharmaceutical sector aimed at promoting ethical principles to advance patient welfare and boost the national integrity campaign. Through the Food and Drug Administration (FDA), the Philippines is expected to fully implement the Mexico City Principles for Voluntary Codes of Business Ethics for the Biopharmaceutical Sector or the Mexico City Principles (MCP) which was endorsed during the 19th Asia Pacific Economic Cooperation (APEC) Economic Leaders Meeting in Hawaii. The adoption of the Mexico City Principles highlights the strong commitment of the Government to promote a whole-of-society approach to integrity that will ultimately benefit Filipino patients. Ethical relationships are crucial to our mission of developing and making quality medicines available. The implementation of the MCP is a milestone for the Philippine healthcare sector and we call on everyone to respect these Principles, said Thomas Weigold, president of the Pharmaceutical and Healthcare Association of the Philippines (PHAP), which is composed of 37 member companies. The MCP asserts that ethical interactions help ensure that medical decisions are made in the best interests of patients and should be guided by six principles namely healthcare and patient focus, integrity, independence, legitimate intent, transparency and accountability. …